Toxicological Studies of (212)Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

Faced with the novelty of a (212)Pb-labeled monoclonal antibody (mAb) for clinical translation, concerns were expressed by the Food and Drug Administration (FDA) regarding (212)Pb prematurely released from the mAb-chelate conjugate. The objective of this study was to simulate the worst case scenario...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Pharmaceuticals (Basel)
Main Authors: Milenic, Diane E., Molinolo, Alfredo A., Solivella, María S., Banaga, Eileen, Torgue, Julien, Besnainou, Sarah, Brechbiel, Martin W., Baidoo, Kwamena E.
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4588175/
https://ncbi.nlm.nih.gov/pubmed/26213947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph8030416
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares